« Previous
Next »
Seminars in Oncology
Volume 32, Issue 3
, Pages
299-314
, June 2005
Advances in Cytotoxic Chemotherapy for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer
-
Median survivals in phase III trials comparing monotherapy to combination chemotherapy.
Median survivals in phase III trials comparing monotherapy to combination chemotherapy.
-
Memorial Sloan-Kettering Cancer Center treatment algorithm.
Memorial Sloan-Kettering Cancer Center treatment algorithm.
PII: S0093-7754(05)00081-3
doi: 10.1053/j.seminoncol.2005.02.011
© 2005 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Oncology
Volume 32, Issue 3
, Pages
299-314
, June 2005
